Current and historical daily PE Ratio for Camurus AB (
) from 2015 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Camurus AB stock (OSTO:CAMX) PE ratio as of Jun 09 2024 is 76.89.
More Details
Camurus AB (OSTO:CAMX) PE Ratio (TTM) Chart
Camurus AB (OSTO:CAMX) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1284
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Camurus AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 76.9 | 2024-04-03 | 65.5 |
| 2024-06-07 | 76.9 | 2024-04-02 | 64.8 |
| 2024-06-05 | 75.7 | 2024-03-28 | 65.2 |
| 2024-06-04 | 76.3 | 2024-03-27 | 69.6 |
| 2024-06-03 | 77.7 | 2024-03-26 | 70.0 |
| 2024-05-31 | 74.6 | 2024-03-25 | 68.6 |
| 2024-05-30 | 69.1 | 2024-03-22 | 68.2 |
| 2024-05-29 | 68.7 | 2024-03-21 | 68.5 |
| 2024-05-28 | 70.0 | 2024-03-20 | 66.9 |
| 2024-05-27 | 70.3 | 2024-03-19 | 66.4 |
| 2024-05-24 | 72.0 | 2024-03-18 | 65.6 |
| 2024-05-23 | 70.7 | 2024-03-15 | 68.2 |
| 2024-05-22 | 71.9 | 2024-03-14 | 66.8 |
| 2024-05-21 | 71.3 | 2024-03-13 | 66.8 |
| 2024-05-20 | 73.8 | 2024-03-12 | 66.8 |
| 2024-05-17 | 72.0 | 2024-03-11 | 66.0 |
| 2024-05-16 | 71.9 | 2024-03-08 | 65.8 |
| 2024-05-15 | 72.8 | 2024-03-07 | 66.2 |
| 2024-05-14 | 72.1 | 2024-03-06 | 64.5 |
| 2024-05-13 | 71.9 | 2024-03-05 | 65.4 |
| 2024-05-10 | 72.4 | 2024-03-04 | 64.8 |
| 2024-05-08 | 68.7 | 2024-03-01 | 62.6 |
| 2024-05-07 | 63.7 | 2024-02-29 | 60.9 |
| 2024-05-06 | 62.0 | 2024-02-28 | 60.8 |
| 2024-05-03 | 63.8 | 2024-02-27 | 59.8 |
| 2024-05-02 | 63.5 | 2024-02-26 | 59.6 |
| 2024-04-30 | 64.0 | 2024-02-23 | 60.4 |
| 2024-04-29 | 63.7 | 2024-02-22 | 59.5 |
| 2024-04-26 | 62.9 | 2024-02-21 | 59.6 |
| 2024-04-25 | 61.2 | 2024-02-20 | 60.3 |
| 2024-04-24 | 61.5 | 2024-02-19 | 59.1 |
| 2024-04-23 | 62.0 | 2024-02-16 | 58.7 |
| 2024-04-22 | 61.0 | 2024-02-15 | 59.6 |
| 2024-04-19 | 62.3 | 2024-02-14 | 72.6 |
| 2024-04-18 | 60.8 | 2024-02-13 | 71.8 |
| 2024-04-17 | 63.9 | 2024-02-12 | 72.6 |
| 2024-04-16 | 63.1 | 2024-02-09 | 70.8 |
| 2024-04-15 | 62.7 | 2024-02-08 | 71.8 |
| 2024-04-12 | 65.4 | 2024-02-07 | 73.7 |
| 2024-04-11 | 65.4 | 2024-02-06 | 73.2 |
| 2024-04-10 | 64.6 | 2024-02-05 | 70.7 |
| 2024-04-09 | 64.6 | 2024-02-02 | 68.4 |
| 2024-04-08 | 66.0 | 2024-02-01 | 69.9 |
| 2024-04-05 | 64.8 | 2024-01-31 | 69.1 |
| 2024-04-04 | 65.2 | 2024-01-30 | 71.5 |
Camurus AB (OSTO:CAMX) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Camurus AB
ISIN : SE0007692850
Compare
Compare
Traded in other countries / regions
CAMX.Sweden0RD1.UKCAMRF.USA7CA.Germany IPO Date
2015-12-03Description
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers